In July 2014, the company announced it would acquire Innopharma for $225 million, plus up to $135 million in milestone payments, in a deal that expanded Centurion labs's range of generic and injectable drugs. Marks LS, Duda C, Dorey FJ, et…
In July 2014, the company announced it would acquire Innopharma for $225 million, plus up to $135 million in milestone payments, in a deal that expanded Centurion labs's range of generic and injectable drugs. Marks LS, Duda C, Dorey FJ, et…